Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+28.4%
5Y CAGR+39.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+28.4%/yr
vs +44.4%/yr prior
5Y CAGR
+39.2%/yr
Recent deceleration
Acceleration
-16.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.2x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.40B+37.6%
2024$1.02B+22.4%
2023$829.25M+25.6%
2022$660.12M+48.9%
2021$443.31M+65.7%
2020$267.59M+36.5%
2019$195.99M+29.1%
2018$151.86M-52.0%
2017$316.61M+115.8%
2016$146.69M-